Literature DB >> 11707436

Physiological substrates for human lysosomal beta -hexosaminidase S.

Stefan T Hepbildikler1, Roger Sandhoff, Melanie Kolzer, Richard L Proia, Konrad Sandhoff.   

Abstract

Human lysosomal beta-hexosaminidases remove terminal beta-glycosidically bound N-acetylhexosamine residues from a number of glycoconjugates. Three different isozymes composed of two noncovalently linked subunits alpha and beta exist: Hex A (alphabeta), Hex B (betabeta), and Hex S (alphaalpha). While the role of Hex A and B for the degradation of several anionic and neutral glycoconjugates has been well established, the physiological significance of labile Hex S has remained unclear. However, the striking accumulation of anionic oligosaccharides in double knockout mice totally deficient in hexosaminidase activity but not in mice expressing Hex S (Sango, K., McDonald, M. P., Crawley, J. N., Mack, M. L., Tifft, C.J., Skop, E., Starr, C. M., Hoffmann, A., Sandhoff, K., Suzuki, K., and Proia, R. L., (1996) Nat. Genet. 14, 348-352) prompted us to reinvestigate the substrate specificity of Hex S. To identify physiological substrates of Hex S, anionic and neutral oligosaccharides excreted in the urine of the double knockout mice were isolated and analyzed. Using ESI-MS/MS and glycosidase digestion the anionic glycans were identified as products of incomplete dermatan sulfate degradation whereas the neutral storage oligosaccharides were found to be fragments of N-glycan degradation. In vitro, recombinant Hex S was highly active on water-soluble and amphiphilic glycoconjugates including artificial substrates, sulfated GAG fragments, and the sulfated glycosphingolipid SM2. Hydrolysis of membrane-bound SM2 by the recombinant Hex S was synergistically stimulated by the GM2 activator protein and the lysosomal anionic phospholipid bis(monoacylglycero)phosphate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11707436     DOI: 10.1074/jbc.M105457200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Hexosaminidase assays.

Authors:  Michaela Wendeler; Konrad Sandhoff
Journal:  Glycoconj J       Date:  2009-11       Impact factor: 2.916

2.  Membrane lipids regulate ganglioside GM2 catabolism and GM2 activator protein activity.

Authors:  Susi Anheuser; Bernadette Breiden; Günter Schwarzmann; Konrad Sandhoff
Journal:  J Lipid Res       Date:  2015-07-14       Impact factor: 5.922

3.  Metabolomics profiling reveals profound metabolic impairments in mice and patients with Sandhoff disease.

Authors:  Li Ou; Michael J Przybilla; Chester B Whitley
Journal:  Mol Genet Metab       Date:  2018-09-14       Impact factor: 4.797

4.  Crystal structure of β-hexosaminidase B in complex with pyrimethamine, a potential pharmacological chaperone.

Authors:  Katherine S Bateman; Maia M Cherney; Don J Mahuran; Michael Tropak; Michael N G James
Journal:  J Med Chem       Date:  2011-01-25       Impact factor: 7.446

5.  Crystallographic structure of human beta-hexosaminidase A: interpretation of Tay-Sachs mutations and loss of GM2 ganglioside hydrolysis.

Authors:  M Joanne Lemieux; Brian L Mark; Maia M Cherney; Stephen G Withers; Don J Mahuran; Michael N G James
Journal:  J Mol Biol       Date:  2006-04-27       Impact factor: 5.469

6.  Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.

Authors:  Brian L Mark; Don J Mahuran; Maia M Cherney; Dalian Zhao; Spencer Knapp; Michael N G James
Journal:  J Mol Biol       Date:  2003-04-11       Impact factor: 5.469

7.  Human neutrophils secrete bioactive paucimannosidic proteins from azurophilic granules into pathogen-infected sputum.

Authors:  Morten Thaysen-Andersen; Vignesh Venkatakrishnan; Ian Loke; Christine Laurini; Simone Diestel; Benjamin L Parker; Nicolle H Packer
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

8.  A novel role of the Batten disease gene CLN3: association with BMP synthesis.

Authors:  Judith A Hobert; Glyn Dawson
Journal:  Biochem Biophys Res Commun       Date:  2007-04-19       Impact factor: 3.575

9.  Production of recombinant beta-hexosaminidase A, a potential enzyme for replacement therapy for Tay-Sachs and Sandhoff diseases, in the methylotrophic yeast Ogataea minuta.

Authors:  Hiromi Akeboshi; Yasunori Chiba; Yoshiko Kasahara; Minako Takashiba; Yuki Takaoka; Mai Ohsawa; Youichi Tajima; Ikuo Kawashima; Daisuke Tsuji; Kohji Itoh; Hitoshi Sakuraba; Yoshifumi Jigami
Journal:  Appl Environ Microbiol       Date:  2007-06-08       Impact factor: 4.792

10.  Gene expression and activity of cartilage degrading glycosidases in human rheumatoid arthritis and osteoarthritis synovial fibroblasts.

Authors:  Mária Pásztói; György Nagy; Pál Géher; Tamás Lakatos; Kálmán Tóth; Károly Wellinger; Péter Pócza; Bence György; Marianna C Holub; Agnes Kittel; Krisztina Pálóczy; Mercédesz Mazán; Péter Nyirkos; András Falus; Edit I Buzas
Journal:  Arthritis Res Ther       Date:  2009-05-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.